Saltar al contenido principal

Políticas de cobertura clínica de farmacia adoptadas por Humana Healthy Horizons in Ohio

Las políticas de cobertura clínica son recursos para los médicos y otros profesionales de cuidado de la salud contratados por Humana que brindan atención a nuestros afiliados inscritos en Humana Healthy Horizons® in Ohio. Humana Healthy Horizons in Ohio ha adoptado las siguientes políticas de cobertura clínica de farmacia:

Una médica mira su computador portátil en el escritorio

HU_CCP_Abraxane (nab-paclitaxel)_12-09-2022, PDF

HU_CCP_Aduhelm (aducanumab)_12-09-2022, PDF

HU_CCP_Aloxi (palonosetron)_12-09-2022, PDF

HU_CCP_Alpha-1 Proteinase Inhibitors (Aralast NP, Glassia)_12-09-2022, PDF

HU_CCP_Alpha-1 Proteinase Inhibitors (Prolastin-C, Zemaira)_12-09-2022, PDF

HU_CCP_Amvuttra (vutrisiran)_12-09-2022, PDF

HU_CCP_Avsola (infliximab-axxq)_12-09-2022, PDF

HU_CCP_Beovu (brolucizumab)_12-09-2022, PDF

HU_CCP_Bevacizumab products_12-09-2022, PDF

HU_CCP_Bortezomib products (Velcade and Bortezomib for injection)_Coversheet_12-09-2022, PDF

HU_CCP_Byooviz (ranibizumab-nuna)_12-09-2022, PDF

HU_CCP_Carvykti (ciltacabtagene autoleucel)_12-09-2022, PDF

HU_CCP_Corticotropin Products_12-09-2022, PDF

HU_CCP_Empaveli (pegcetacoplan)_12-09-2022, PDF

HU_CCP_Enjaymo (sutimlimab-jome)_12-09-2022, PDF

HU_CCP_Entyvio (vedolizumab)_12-09-2022, PDF

HU_CCP_Evomela (melphalan)_12-09-2022, PDF

HU_CCP_Firazyr (icatibant)_12-09-2022, PDF

HU_CCP_Fyarro (sirolimus protein-bound particles)_12-09-2022, PDF

HU_CCP_Hypomethylating agents_12-09-2022, PDF

HU_CCP_Inflectra (infliximab-dyyb)_12-09-2022, PDF

HU_CCP_IVIG Globulina inmune_12-09-2022, PDF

HU_CCP_Jemperli (dostarlimab-gxly)_12-09-2022, PDF

HU_CCP_Kimmtrak (tebentafusp-tebn)_12-09-2022, PDF

HU_CCP_Korsuva (difelikefalin)_12-09-2022, PDF

HU_CCP_Leqvio (inclisiran)_12-09-2022, PDF

HU_CCP_Levoleucovorin products (Fusilev, Khapzory)_12-09-2022, PDF

HU_CCP_Liposomal doxorubicin_12-09-2022, PDF

HU_CCP_Lucentis (ranibizumab)_12-09-2022, PDF

HU_CCP_Marqibo (vincristine sulfate liposome injection)_12-09-2022, PDF

HU_CCP_Nexviazyme (avalglucosidase-alfa)_12-09-2022, PDF

HU_CCP_Non-Preferred Filgrastim Products_12-09-2022, PDF

HU_CCP_Opdualag (nivolumab and relatlimab-rmbw)_12-09-2022, PDF

HU_CCP_Parsabiv (etelcalcetide)_12-09-2022, PDF

HU_CCP_Pemetrexed Products_12-09-2022, PDF

HU_CCP_Pluvicto (lutetium Lu 177 vipivotide tetraxetan)_12-09-2022, PDF

HU_CCP_Remicade (infliximab)_12-09-2022, PDF

HU_CCP_Renflexis (infliximab-abda)_12-09-2022, PDF

HU_CCP_Rituxan Hycela (rituximab-hyaluronidase)_12-09-2022, PDF

HU_CCP_Rituximab products_12-09-2022, PDF

HU_CCP_Rybrevant (amivantamab)_12-09-2022, PDF

HU_CCP_Rylaze (asparaginase Erwinia chrysanthemi recombinant-rywn)_12-09-2022, PDF

HU_CCP_Ryplazim (plasminogen, human-tvmh)_12-09-2022, PDF

HU_CCP_Saphnelo (anifrolumab-fnia)_12-09-2022, PDF

HU_CCP_Signifor LAR (pasireotide)_12-09-2022, PDF

HU_CCP_Somatuline Depot (lanreotide)_12-09-2022, PDF

HU_CCP_Sustol (granisetron)_12-09-2022, PDF

HU_CCP_Susvimo (ranibizumab)_12-09-2022, PDF

HU_CCP_Tezspire (tezepelumab-ekko)_12-09-2022, PDF

HU_CCP_Tivdak (tisotumab vedotin-tftv)_12-09-2022, PDF

HU_CCP_Vabysmo (faricimab-svoa)_12-09-2022, PDF

HU_CCP_Viscosupplements Coversheet_12-09-2022, PDF

HU_CCP_Vyondys (golodirsen) 53_12-09-2022, PDF

HU_CCP_Vyvgart (efgartigimod alfa-fcab)_12-09-2022, PDF

HU_CCP_Xipere (triamcinolone acetonide)_12-09-2022, PDF

HU_CCP_Zolgensma (onasemnogene abeparvovec-xioi)_12-09-2022, PDF

Acceso a las políticas de cobertura clínica de salud física de Humana Healthy Horizons in Ohio

Acceso a las políticas de cobertura clínica de salud conductual de Humana Healthy Horizons in Ohio